Last updated: May 15, 2024
Sponsor: Massachusetts General Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Respiratory Syncytial Virus (Rsv) Infection
Recurrent Respiratory Papillomatosis
Non-small Cell Lung Cancer
Treatment
N/AClinical Study ID
NCT06412172
HIC# 2000037079
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
History of HPV-associated Recurrent Respiratory Papillomatosis
Has pulmonary lesions
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 100
Study Start date:
April 15, 2024
Estimated Completion Date:
April 15, 2030
Study Description
Connect with a study center
Yale School of Medicine
New Haven, Connecticut 06520
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.